Chemotherapy plus EGFR-TKI as first-line treatment provides better survival for advanced EGFR positive lung adenocarcinoma patients: updated data and exploratory in vitro study

ABSTRACT: To probe into the potential mechanisms contributing to the strong synergistic interaction between gefitinib and pemetrexed, gene expression profiles of PC-9 cells exposed to gefitinib, pemetrexed or combined treatment were analyzed using microarray technique.

ORGANISM(S): Homo sapiens

SUBMITTER: Yuqing Lou 

PROVIDER: E-MTAB-8661 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress